# Fluoroethyltyrosine for the Evaluation of Intracranial Neoplasm

> **NCT06474533** · — · RECRUITING · sponsor: **Thomas Hope** · enrollment: 199 (estimated)

## Conditions studied

- Intracranial Neoplasm

## Interventions

- **DRUG:** Fluorethyltyrosine (18-F)
- **PROCEDURE:** Positron Emission Tomography (PET)

## Key facts

- **NCT ID:** NCT06474533
- **Lead sponsor:** Thomas Hope
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-21
- **Primary completion:** 2028-08-31
- **Final completion:** 2028-08-31
- **Target enrollment:** 199 (ESTIMATED)
- **Last updated:** 2026-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06474533

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06474533, "Fluoroethyltyrosine for the Evaluation of Intracranial Neoplasm". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06474533. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*